MedTrace Logo

Biomarkers and SNP-polymorphisms in Post-infarction Cardiac Remodeling

NCT04296253 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-10-06

No results posted yet for this study

Summary

The purpose of this study is to explore the serum levels of pro- and anti-inflammatory biomarkers and angiogenic growth factors and SNP polymorphisms of the promoter regions of their genes as well as to determine their role in the development of adverse cardiac remodeling in patients with acute ST-segment elevation myocardial infarction.

Conditions

Interventions

GENETIC

SNP polymorphisms of the promoter regions pro - and anti-inflammatory cytokines and angiogenic growth factor

blood sampling

Sponsors & Collaborators

  • Tomsk National Research Medical Center of the Russian Academy of Sciences

    lead OTHER

Principal Investigators

  • Vyacheslav Ryabov, MD, PhD · Cardiology Research Institute, Tomsk NRMC

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04296253 on ClinicalTrials.gov